Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stocks, par value $0,0001 per share
-
Shares outstanding
-
58,548,563
-
Total 13F shares
-
25,749,741
-
Share change
-
+659,103
-
Total reported value
-
$505,464,807
-
Put/Call ratio
-
7.6%
-
Price per share
-
$19.63
-
Number of holders
-
77
-
Value change
-
+$1,201,394
-
Number of buys
-
46
-
Number of sells
-
35
Institutional Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) as of Q4 2021
As of 31 Dec 2021 BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) had 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 25,749,741 shares of stock of the company.
Largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Soleus Capital Management, L.P., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, Cormorant Asset Management, LP, BlackRock Inc., STATE STREET CORP, GREAT POINT PARTNERS LLC, and BAKER BROS. ADVISORS LP.
This table shows 77 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.